Deep Track Capital, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value (DNTH)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value
Symbol
DNTH
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 08:09:59 UTC
Date of event
30 Sep 2025
Previous filing
24 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 0% 0 0 0 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 0% 0 0 0 /s/ David Kroin David Kroin, Director
David Kroin 0% 0 0 0 /s/ David Kroin David Kroin